Medication info

Januwattin 25 mg (Sitagliptin Hydrochloride Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›28.34mg / 1 tablet
Manufacturer / importer
Farmgen Science Co., Ltd.
Appearance
Bright yellow-orange round film-coated tablet
Packaging
100 tablets/bottle, 30 tablets/bottle
Approval status
Active

MFDS item code 202102458 · Approved 2021.03.19

Summary

Main use
Improves blood glucose control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medication is administered at 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. It may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions, 5. General Precautions). Patients with renal impairment Because dosage adjustment is required according to renal function, assessment of renal function is recommended before starting this medication and periodically thereafter. 1. No dosage adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medication may be administered without regard to the timing of dialysis.

Ingredients

Manufacturer
Farmgen Science Co., Ltd.

Efficacy & effects

Improves blood glucose control in patients with type 2 diabetes mellitus

  • Difficulty in blood sugar control for patients with type 2 diabetes
View approved original text

This medication helps patients with type 2 diabetes improve blood sugar control alongside diet and exercise. It can be administered alone, and in cases where blood sugar control is difficult with monotherapy and there has been no previous treatment for diabetes, it can be used in combination with metformin. Additionally, this medication can be used in combination with sulfonylureas, metformin, thiazolidinediones, or insulin when blood sugar control is insufficient with monotherapy. Even in cases where blood sugar control is difficult despite combination therapy with multiple medications, this medication can be used to effectively manage blood sugar. It aids in improving blood sugar control through various therapeutic approaches.

How to take

Adult dose

This medication is administered at 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. It may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions, 5. General Precautions). Patients with renal impairment Because dosage adjustment is required according to renal function, assessment of renal function is recommended before starting this medication and periodically thereafter. 1. No dosage adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dosage adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medication may be administered without regard to the timing of dialysis.

Precautions

This medication may cause severe allergic reactions after administration; therefore, if symptoms such as skin rash or difficulty breathing occur, discontinue use immediately and consult a doctor. Also, during treatment with this medication, symptoms of pancreatitis, such as severe abdominal pain, vomiting, and nausea, may occur, so careful observation is required. This medication should not be used in patients with type 1 diabetes or diabetic ketoacidosis, nor in patients with hypersensitivity to this medication. Patients with impaired kidney function should have their dosage adjusted; regular kidney function tests are recommended. Hypoglycemic symptoms may occur during treatment with this medication, and the risk of hypoglycemia is higher, especially when used in conjunction with insulin or sulfonylureas. Therefore, if hypoglycemic symptoms occur, blood sugar should be checked immediately and appropriate measures should be taken. This medication may cause side effects such as headache, upper respiratory infection, nasopharyngitis, diarrhea, nausea, constipation, muscle pain, limb pain, back pain, pruritus, thrombocytopenia, indigestion, dizziness, increased triglycerides, increased low-density lipoprotein, hyperglycemia, weight loss, hypernatremia, and erectile dysfunction. If severe joint pain or skin blistering symptoms occur during treatment, consult a doctor promptly, and if necessary, this medication may be discontinued. Pregnant or breastfeeding women should avoid this medication, and safety and effectiveness have not been established for children under the age of 18. Elderly patients may have decreased kidney function; therefore, dosage adjustment and kidney function tests are necessary. In the event of overdose, seek immediate medical attention for appropriate treatment, as this medication can be partially removed by hemodialysis. Finally, this medication may interact with other drugs; therefore, inform your doctor or pharmacist if you are taking any other medications.

Side effects

Anaphylaxis, angioedema, Stevens-Johnson syndrome, acute pancreatitis, hypoglycemia, nasopharyngitis, upper respiratory infection, headache, diarrhea, abdominal pain, nausea, peripheral edema, dyspepsia, dizziness, elevated liver enzymes, acute renal failure, constipation, vomiting, severe and disability-associated arthralgia, blistering dermatitis herpetiformis, myalgia, limb pain, back pain, interstitial lung disease, pruritus, thrombocytopenia, rhabdomyolysis, pneumonia, diabetic complications, metabolic acidosis, falls, cardiac arrest, increased serum triglycerides, gastritis, weight loss, hypertension, hypernatremia, erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent the ingress of air or moisture. It is best kept at room temperature, specifically between 1 to 30 degrees Celsius, to maintain its effectiveness.

Appearance and packaging

Appearance

Bright yellow-orange round film-coated tablet

Package unit

100 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.